Target intelligence / Profile preview

Dual specificity phosphatase 9 (DUSP9)

Target
DUSP9
Molecular classification
Enzyme, Dual specificity phosphatase, Mitogen-activated protein kinase phosphatase (MKP), Protein tyrosine phosphatase, Protein serine/threonine phosphatase
01

Overview

Dual specificity phosphatase 9 (DUSP9), also known as MKP-4, is a member of the dual specificity phosphatase family that catalyzes the removal of phosphate groups from both phosphotyrosine and phosphoserine/threonine residues on protein substrates. DUSP9 plays a crucial role in the inactivation of mitogen-activated protein kinases (MAPKs), particularly the ERK, JNK, and p38 families, thus acting as a key negative regulator of MAPK signal transduction. It is expressed in various tissues, localizes predominantly in the cytoplasm, and helps fine-tune cell responses to stress, growth factors, and cytokines, being implicated in the regulation of insulin signaling, cancer cell resistance, and inflammation.

Other names
MKP-4Mitogen-activated protein kinase phosphatase 4
02

Mechanism of action

Drugs or molecules that increase DUSP9 (MKP-4) activity can dephosphorylate and inactivate MAP kinases (ERK, JNK, p38), thereby negatively regulating pro-inflammatory and stress signaling cascades and potentially reversing insulin resistance

03

Biological functions

Signal transductionNegative regulation of MAPK signalingDephosphorylation of ERK, JNK, and p38 kinasesCellular response to stressRegulation of insulin signaling
04

Disease associations

CancerDiabetes (Insulin resistance, type 2 diabetes, obesity-related insulin resistance)Inflammation
05

Safety considerations

Modulating DUSP9 could impact broad cellular signaling cascades, leading to unpredictable effects on cell proliferation, survival, and differentiation, with risks of impaired immune response or altered metabolism
06

Interacting drugs

No approved or clinically used drugs directly targeting DUSP9 identified in current literature
07

Biomarkers

DUSP9 expression may serve as a biomarker of MAPK pathway activity, chemotherapeutic resistance, and cancer stemness in some cancers; potential biomarker in studies of insulin resistance

Beyond the preview

Go deeper on Dual specificity phosphatase 9 (DUSP9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dual specificity phosphatase 9 (DUSP9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call